Marijuana-Based Drug Seeking Approval in US for MS
WNEP-TV, PA
A drug company in Great Britian wants to market a marijuana based medicine to treat multiple sclerosis and nervous system pain in the States.
GW Pharmaceuticals says it's accelerating plans to introduce cannabis-based medicines into the America. Sativex, is an under-the-tongue spray to treat the symptoms of multiple sclerosis and neuropathic pain.
The drug spray already won approval in Canada.
Google news search: GW Pharmaceuticals
A drug company in Great Britian wants to market a marijuana based medicine to treat multiple sclerosis and nervous system pain in the States.
GW Pharmaceuticals says it's accelerating plans to introduce cannabis-based medicines into the America. Sativex, is an under-the-tongue spray to treat the symptoms of multiple sclerosis and neuropathic pain.
The drug spray already won approval in Canada.
Google news search: GW Pharmaceuticals
posted by Loretta Nall at
3:55 AM
0 Comments:
Post a Comment
<< Home